Cancer BiologybioRxiv
Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma
H. H.-L. Huang, I. D. Ferguson, A. M. Thornton…·A. P. Wiita
The paper shows proteasome inhibitors modulate splicing in multiple myeloma, revealing spliceosome inhibition as a therapeutic target.
DOI 10.1038/s41467-020-15521-4